相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does leflunomide have a role in giant cell arteritis? An open-label study
Alojzija Hocevar et al.
CLINICAL RHEUMATOLOGY (2019)
Large-Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease?
Francesco Muratore et al.
ARTHRITIS CARE & RESEARCH (2018)
2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis
Anne-Kathrin Rausch Osthoff et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Christian Dejaco et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients
Hubert de Boysson et al.
AUTOIMMUNITY REVIEWS (2018)
Comparative effectiveness of 18F-FDG PET-CT and contrast-enhanced CT in the diagnosis of suspected large-vessel vasculitis
Sriram Vaidyanathan et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Ophthalmic manifestations of giant cell arteritis
Ivana Vodopivec et al.
RHEUMATOLOGY (2018)
Large-vessel giant cell arteritis: diagnosis, monitoring and management
Matthew J. Koster et al.
RHEUMATOLOGY (2018)
Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group
Stavros Chrysidis et al.
RMD OPEN (2018)
High-Resolution Magnetic Resonance Imaging of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Cohort Study
Maxime Rheaume et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Trial of Tocilizumab in Giant-Cell Arteritis
J. H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Exercise in Takayasu Arteritis: Effects on Inflammatory and Angiogenic Factors and Disease-Related Symptoms
Diego S. Oliveira et al.
ARTHRITIS CARE & RESEARCH (2017)
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis
Carol A. Langford et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?
Andreas P. Diamantopoulos et al.
RHEUMATOLOGY (2016)
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
Cindy Strehl et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression
Carmelo Scarpignato et al.
BMC MEDICINE (2016)
The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis
Karin Jakobsson et al.
BMC MUSCULOSKELETAL DISORDERS (2016)
The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study
Raashid Luqmani et al.
HEALTH TECHNOLOGY ASSESSMENT (2016)
Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 Patients
Eric Liozon et al.
JOURNAL OF RHEUMATOLOGY (2016)
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
Peter M. Villiger et al.
LANCET (2016)
Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis A real-life prospective study
Delphine Lariviere et al.
MEDICINE (2016)
Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)
B. Bienvenu et al.
REVUE DE MEDECINE INTERNE (2016)
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
Christian Dejaco et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Guideline panels should not GRADE good practice statements COMMENT
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients
Alfonso Iorio et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients
Alfonso Iorio et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
3T MRI Reveals Extra- and Intracranial Involvement in Giant Cell Arteritis
S. Siemonsen et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
Joanna C. Robson et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Projected Worldwide Disease Burden from Giant Cell Arteritis by 2050
Elisabeth De Smit et al.
JOURNAL OF RHEUMATOLOGY (2015)
Large-vessel giant cell arteritis: a cohort study
Francesco Muratore et al.
RHEUMATOLOGY (2015)
Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis
Sarah Louise Mackie et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
Raimund Erbel et al.
EUROPEAN HEART JOURNAL (2014)
Relapses in Patients With Giant Cell Arteritis Prevalence, Characteristics, and Associated Clinical Findings in a Longitudinally Followed Cohort of 106 Patients
Marco A. Alba et al.
MEDICINE (2014)
Giant Cell Arteritis: Diagnostic Accuracy of MR Imaging of Superficial Cranial Arteries in Initial Diagnosis-Results from a Multicenter Trial
Thorsten Klink et al.
RADIOLOGY (2014)
BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis
Eleana Ntatsaki et al.
RHEUMATOLOGY (2014)
Large vessel vasculitis in elderly patients: early diagnosis and steroid-response evaluation with FDG-PET/CT and contrast-enhanced CT
Go Muto et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Diagnostic Value of Color Doppler Ultrasonography of Temporal Arteries and Large Vessels in Giant Cell Arteritis: A Consecutive Case Series
Andreas P. Diamantopoulos et al.
ARTHRITIS CARE & RESEARCH (2014)
Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis
Tanaz A. Kermani et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
N. Duru et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
Jeff Andrews et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Optimized glucocorticoid therapy: Teaching old drugs new tricks
Cindy Strehl et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Leflunomide as a Corticosteroid-Sparing Agent in Giant Cell Arteritis and Polymyalgia Rheumatica: A Case Series
Andreas P. Diamantopoulos et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography
Sergio Prieto-Gonzalez et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis
Hisham M. Habib et al.
CLINICAL RHEUMATOLOGY (2012)
Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series
T. Adizie et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
S. van Assen et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Application of GRADE: Making evidence-based recommendations about diagnostic tests in clinical practice guidelines
Jonathan Hsu et al.
IMPLEMENTATION SCIENCE (2011)
GRADE guidelines: 2. Framing the question and deciding on important outcomes
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors
Sarah L. Mackie et al.
RHEUMATOLOGY (2011)
Illustrated histopathologic classification criteria for selected vasculitis syndromes
J. T. Lie
ARTHRITIS AND RHEUMATISM (2010)
Diagnostic Value of T2-Weighted Imaging for the Detection of Superficial Cranial Artery Inflammation in Giant Cell Arteritis
Julia Geiger et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
BSR and BHPR guidelines for the management of polymyalgia rheumatica
Bhaskar Dasgupta et al.
RHEUMATOLOGY (2010)
BSR and BHPR guidelines for the management of giant cell arteritis
Bhaskar Dasgupta et al.
RHEUMATOLOGY (2010)
American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Jennifer M. Grossman et al.
ARTHRITIS CARE & RESEARCH (2010)
Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies
J. L. Brozek et al.
ALLERGY (2009)
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis
C. Salvarani et al.
RHEUMATOLOGY (2009)
Polymyalgia rheumatica and giant-cell arteritis
Carlo Salvarani et al.
LANCET (2008)
Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis
W. A. Schmidt et al.
RHEUMATOLOGY (2008)
Genomic and nongenomic effects of glucocorticoids
Cindy Stahn et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects
V. M. Martinez-Taboada et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Diagnostic value of high-resolution MR imaging in giant cell arteritis
T. A. Bley et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2007)
Adjunctive methotrexate for treatment of giant cell arteritis -: An individual patient data meta-analysis
Alfred D. Mahr et al.
ARTHRITIS AND RHEUMATISM (2007)
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis - A randomized trial
Gary S. Hoffman et al.
ANNALS OF INTERNAL MEDICINE (2007)
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids - A double-blind, placebo-controlled, randomized prospective clinical trial
Mehrdad Mazlumzadeh et al.
ARTHRITIS AND RHEUMATISM (2006)
Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001
L. Smeeth et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
No additional steroid-sparing effect of cyclosporine A in giant cell arteritis
C. Schaufelberger et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2006)
Population-based assessment of adverse events associated with long-term glucocorticoid use
Jeffrey R. Curtis et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis
Maria Karahaliou et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging
TA Bley et al.
ARTHRITIS AND RHEUMATISM (2005)
The role of color duplex sonography in the diagnosis of giant cell arteritis
A Romera-Villegas et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2004)
Color-coded sonography in suspected temporal arteritis - experiences after 83 cases
M Reinhard et al.
RHEUMATOLOGY INTERNATIONAL (2004)
Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain -: A population-based study
MA Gonzalez-Gay et al.
MEDICINE (2004)
Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis
MA Gonzalez-Gay et al.
MEDICINE (2004)
The use of ultrasound as an aid in the diagnosis of giant cell arteritis: a pilot study comparing histological features with ultrasound findings
H Murgatroyd et al.
EYE (2003)
Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis - A population-based study over 50 years
DM Nuenninghoff et al.
ARTHRITIS AND RHEUMATISM (2003)
The utility of color duplex ultrasonography in the diagnosis of temporal arteritis
CJ LeSar et al.
JOURNAL OF VASCULAR SURGERY (2002)
Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature
SS Hayreh et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2002)
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
GS Hoffman et al.
ARTHRITIS AND RHEUMATISM (2002)
Evidence base of clinical diagnosis - The architecture of diagnostic research
DL Sackett et al.
BRITISH MEDICAL JOURNAL (2002)
Does this patient have temporal arteritis?
GW Smetana et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Combined treatment of giant-cell arteritis with methotrexate and prednisone -: A randomized, double-blind, placebo-controlled trial
JA Jover et al.
ANNALS OF INTERNAL MEDICINE (2001)
Pathogenic principles in giant cell arteritis
CM Weyand et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2000)
Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch
D Blockmans et al.
AMERICAN JOURNAL OF MEDICINE (2000)
分享论文
